American pharmaceutical giant Pfizer is seeking regulatory approval in ... s version of the RSV vaccine, Arexvy, is also available for those aged 60 and above in the US, EU, the United Kingdom ...
Dr. Belcher says RSV overwhelmed children’s hospitals in 2022 and hit earlier and worse than expected. This year, experts say ...
Yes, there are two FDA-approved vaccines for RSV — one for older adults, and one for both older adults and pregnant people. The FDA approved the first-ever RSV vaccine in May 2023. The shot ...
Federal officials have been working with companies to find ways to boost the supply of the new vaccine for newborns.
American pharmaceutical giant filed application for regulatory approval of its Abrysvo jab in Hong Kong last month, source familiar with situation says.
More than a third of Americans say they are worried that they or one of their family members will contract a seasonal ...
Respiratory syncytial virus, more commonly known as RSV ... the drug is facing major shortages. READ: First vaccine for chikungunya virus, an 'emerging global health threat,' gets FDA approval "This ...
New vaccines against RSV are now available in Waco for the elderly and those who are pregnant regardless of income or insurance. “It is critical that older adults, 60 years and up, get ...
Besides Pfizer’s fast-declining COVID-19 sales, vaccine rival GSK is giving the New York drugmaker another reason to worry. In the first ... approval as a maternal vaccine to prevent RSV in ...
Both shots were approved earlier this year--the first RSV vaccines after decades of unsuccessful attempts--and the third quarter was the first full quarter for which sales were reported.
